Sources | Names Used |
---|---|
CTRPv2 | decitabine:navitoclax (2:1 mol/mol) |
PharmacoGx | decitabine:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SMARCA4 | CTRPv2 | pan-cancer | AAC | 0.23 | 3e-11 |
mRNA | ZNF439 | CTRPv2 | pan-cancer | AAC | 0.22 | 3e-11 |
mRNA | FIZ1 | CTRPv2 | pan-cancer | AAC | 0.21 | 3e-11 |
mRNA | FAM57B | CTRPv2 | pan-cancer | AAC | 0.22 | 3e-11 |
mRNA | ZNF428 | CTRPv2 | pan-cancer | AAC | 0.22 | 3e-11 |
mRNA | DNMT3A | CTRPv2 | pan-cancer | AAC | 0.22 | 4e-11 |
mRNA | CDKN2D | CTRPv2 | pan-cancer | AAC | 0.21 | 4e-11 |
mRNA | FBXO25 | CTRPv2 | pan-cancer | AAC | 0.21 | 4e-11 |
mRNA | UNC5A | CTRPv2 | pan-cancer | AAC | 0.22 | 5e-11 |
mRNA | ZNF397 | CTRPv2 | pan-cancer | AAC | 0.21 | 6e-11 |